A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease by Marrinan, S, Otiker, T, Vasist, L, Gibson, R, Sarai, B, Barton, M, Richards, D, Hellström, P, Nyholm, D, Dukes, G, Burn, D

The primacy of public health considerations in defining poor quality medicines. by Newton, P, Amin, A, Bird, C, Passmore, P, Dukes, G, Tomson, G, Simons, B, Bate, R, Guerin, P, White, N

The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-contro... by Chapman, M, Deane, A, O'Connor, S, Nguyen, N, Fraser, R, Richards, D, Hacquoil, K, Vasist Johnson, L, Barton, M, Dukes, G

BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial by Hegade, VS, Kendrick, SFW, Dobbins, RL, Miller, SR, Richards, D, Storey, J, Dukes, G, Gilchrist, K, Vallow, S, Alexander, GJ, Corrigan, M, Hirschfield, GM, Jones, DEJ

Nutrition adequacy therapeutic enhancement in the critically ill: a randomized double‐blind, placebo‐controlled trial of the motilin receptor agonist camicinal (GSK962040): the NUT... by Deane, A, Lamontagne, F, Dukes, G, Neil, D, Vasist, L, Barton, M, Hacquoil, K, Ou, X, Richards, D, Stelfox, H, Mehta, S, Day, A, Chapman, M, Heyland, D